Major projects

• Clinical development and medical affairs of irinotecan and oxaliplatin
• Clinical development of istradefylline
• Preclinical studies and medical affairs of 5-fluorouracil, mitomycin C, adriamycin, farmorubicin, vinorelbine, medroxyprogesterone and G-CSF

Experience

• Since 2017 Scientific Director, Takanawa Pharma
• 2014 – 2016 Senior Officer, Nichi-Iko
• 2013 – 2014 Director, Global Study Clinical Research Department, CMIC
• 2005 – 2013 Deputy General Manager, Yakult
• 1975 – 2005 General Manager, Deputy GM, Managing Researcher and Researcher, Kyowa Hakko

Education

• Ph.D. in Pharma Science, Tokyo University
• B.Sc. in Pharma Science, Tokyo University
• Visiting scientist at Japanese Foundation for Cancer Research
• Visiting scientist at National Cancer Institute, Bethesda, USA

Civic Engagement

• Member of ASCO and AACR
• Member of JSMO (Japanese equivalent of ASCO)